Research and Markets, the largest resource for market research information in world providing essential market research reports, industry research, industry analysis, forecasts, market studies, company profiles and country reports.
Welcome - Register - Login - Help/FAQ - 0 items View Basket
Worlds Largest Market Research Resource - 1516199 Live Reports
Search Research and Markets
  Search
Enter keywords, a title or
a report id number below.





Advanced   
Company search
Register for free email updates of market research
Currency
  Select a currency for use throughout the site



Viewing report

Order by Fax
Ask a Question
Printer Friendly
PDF Brochure
Hard CopyAdd to Basket
Live Chat Live Help Software for Website

Textbook of Hemophilia, 2nd Edition

John Wiley and Sons Ltd, June 2010, Pages: 476


  Description  
   Table of Contents   
   Author   
    
    
     
  Enquire before Buying   
  Send to a Friend   

The Textbook of Hemophilia has become a definitive resource for all those managing hemophilia patients. It covers all the common and rare bleeding disorders, both in terms of clinical management as well as the genetic, laboratory, financial and psychological aspects.

This second edition covers all the latest developments in the field of hemophilia, with new chapters on:

- The genetic and molecular basis of inherited blood disorders
- How to manage adolescent and older patients
- Emergency medicine and inherited blood disorders
- National hemophilia databases

Drawing on the vast experience of the authors, the aim of this textbook remains the same - to improve the care of patients suffering from hemophilia. The book is full of detailed guidance and advice on everyday clinical questions making it invaluable to all trainee and practicing hematologists.


Product samples

A sample for this product is available. Please Login/Register to download this sample.

Customers who bought this item also bought

Do Emerging Therapies Offer Better Treatment Options for Hemophilia Patients?

Stakeholder Opinions: Hemophilia - The harsh reality of commercialising a great research opportunity?

Competitor Analysis: Coagulation Factors

Coagulation Factors 2011 - Who does meet the market needs? A Pipeline Assessment, Market Survey and Corporate Benchmark Analysis

Hemophilia Therapeutics - Pipeline Assessment and Market Forecasts to 2018

Blood Disorders Therapeutics Market to 2017 - Patent Expiries of Lovenox, Plavix, Procrit/Epogen, Aranesp and Neulasta Will Slow Down Growth

Practical Hemostasis and Thrombosis, 2nd Edition

Personalized Medicine - Scientific and Commercial Aspects

Coagulation Disorders Market to 2017 - Hemophilia A, the Largest Segment, to Witness a Decline in Growth Rate due to Patent Expiries and Weak Pipeline

Cardiovascular Drug Delivery - Technologies, Markets and Companies



For enquiries please call us on:
  +353-1-415-1241 (GMT Office Hours)
  1-800-526-8630 (US/Canada Toll Free)
  1-917-300-0470 (EST Office Hours)

   All rights reserved. © Copyright 2012 Research and Markets
   Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network


Research and Markets RSS Feeds